MedGenome, backed by Sequoia Capital, LeapFrog Investments, Novo Holdings, Sofina, HDFC, Emerge Ventures, Zodius Capital and International ...

Mahesh Pratapneni, who co‐founded MedGenome with Santhosh, will take over as Group CEO. Dr. Felix Olale, Partner of LeapFrog Investments, w...

The use of genetic tests and genomic medicine is gradually rising in India, underlining the need for a regulatory framework.

MedGenome is a genomics-driven research and diagnostics company involved in decoding the genetic information contained in an individual's g...

"With IFC's support, we will continue to expand our services across India, bringing tests directly to the communities most affected by the ...

Leapfrog, which is currently investing out of its $750 million fourth fund that it raised in 2018, has so far received close to $1.5 billio...

Pune-based Mylab Discovery Solutions was the first Indian company to receive commercial approval to manufacture Covid-19 test kits in the c...

Being the first to get approvals from regulators to produce test kits tipped the scales in their favour.

A look at the shortlisted startups for the Healthcare Innovation and Midas Touch categories for The Economic Times Startup Awards 2020.

There is a significant decline in the quantum of funds as wary investors are holding back due to the fallout of economies in coping with th...

Currently, genomics is widely used in areas such as oncology, infectious diseases (especially tuberculosis), rare diseases, reproductive he...

MedGenome plans to use the funds raised to expand clinical genomic testing to India's tier-2 and tier-3 towns and cities, as well as toward...

MedGenome will use the proceeds to expand the clinical genomic testing market by entering Tier-II and Tier-III towns and cities and “democr...

The round also saw participation from Zodius Capital, former Infosys CEO Kris Gopalakrishnan and former Cognizant CEO Lakshmi Narayanan.

MedGenome has seen the number of samples triple for genetic tests in of samples triple for genetic tests in the last one year.

The July-September quarter also saw a 41% jump compared to the same period last year, which witnessed 79 deals worth $264 million.

“We would use these funds to ensure better collaboration with various research institutions across India,“ chairman and CEO Sam Santhosh sa...